Raloxifene (Evista) osteoporosis drug and... - Cure Parkinson's

Cure Parkinson's

26,582 members27,897 posts

Raloxifene (Evista) osteoporosis drug and PD

genesurf profile image
3 Replies

Research in mice shows that the osteoporosis drug "raloxifene" (brand name Evista) may help prevent dopaminergic neuron loss.

Just wondered if anyone here is taking it already for osteoporosis, and has it helped your PD?

pubmed.ncbi.nlm.nih.gov/276... "... the present results suggest that raloxifene may help preventing the loss of DAergic neurons in the myenteric plexus in an MPTP mouse model of PD, at least in part through its anti-inflammatory effects. This suggests that drug repurposing of raloxifene might represent a promising therapeutic avenue to prevent systemic inflammation and peripheral neuronal dysfunction at early PD stages."

pubmed.ncbi.nlm.nih.gov/214...

Written by
genesurf profile image
genesurf
To view profiles and participate in discussions please or .
Read more about...
3 Replies
park_bear profile image
park_bear

First reference, from the text of the study:

" Mice were divided into 6 groups comprised of 8-9 mice per group and respectively treated with vehicle, raloxifene, or a combination of raloxifene and the GPER1 antagonist G15 for 10 days. On day 5, mice received 4 injections of MPTP at 2-hour intervals, whereas the control groups received only saline. On day 11, mice were killed and the gut was collected." [Brand names and sources of chemicals emitted for readability]

The problem with this kind of study is that it merely shows that the treatment protected the test animals against toxic insult. In the case of actual Parkinson's the toxic insult is typically long gone and what is needed is to clean up the damage, namely, malformed alpha synuclein. What this study did was to prevent damage in the first place. These two things are not the same. This kind of study is so weak it does not really qualify as evidence. What they needed to have done was to apply the toxic insult first, cause the damage, and then see if the treatment cleans up the mess.

The second study no better: " and were injected daily with 17β-estradiol, tamoxifen, raloxifene, PPT and DPN respectively for 5days before 6-OHDA and continued for further 2 weeks."

This kind of nonsense is commonplace. An egregious waste of time and money and opportunity cost.

With all that said, there is nothing wrong with your inquiry as to whether this treatment has actually helped anybody.

genesurf profile image
genesurf in reply topark_bear

It's not for advanced PD. As they said, "... promising therapeutic avenue to prevent systemic inflammation and peripheral neuronal dysfunction at early PD stages". Emphasis on prevention and early.

Evista is commonly prescribed for postmenopausal women to prevent bone loss and reduce the incidence of breast cancer. I am wondering if anyone here has been taking Evista long-term, perhaps even before their PD was diagnosed. And if so, how are they progressing?

park_bear profile image
park_bear in reply togenesurf

Parkinson's symptoms only become apparent after 80 percent of dopamine producing neurons are lost or disabled. So early stage Parkinson's symptoms represent advanced stage neuron loss.

Prevention would be great if we knew we were being subjected to a toxic exposure that could cause Parkinson's. But that occurs many years before diagnosis.

Not what you're looking for?

You may also like...

Osteoporosis, Osteopenia, Parkinson's Disease And Melatonin : The Melatonin Series Continues

Since PwP are at increased risk for Osteoporosis and Osteopenia, I am writing this post to...
chartist profile image

PD & Osteoporosis

I have PD & Osteoporosis. I also have very low levels of vitamin D and supplements aren't helping...
jdc3 profile image

Terazosin for Parkinson's Disease (TZ-PD) Trial

Terazosin ========= Somebody in a different forum posted that the best medicine they are taking for...

Mitochondrial uncoupling ; can this help PD, appears maybe

“Apoptosis induced by MPP+ was ameliorated by NTZ in a dose-dependent manner. In vivo results...

Molecular chaperones for removing misfolded AS

It has been demonstrated that chaperones/co-chaperones interact with PD-related proteins and...